141 related articles for article (PubMed ID: 1532568)
1. Oestrogen sulphatase activity in hormone-dependent and hormone-independent breast-cancer cells: modulation by steroidal and non-steroidal therapeutic agents.
Purohit A; Reed MJ
Int J Cancer; 1992 Apr; 50(6):901-5. PubMed ID: 1532568
[TBL] [Abstract][Full Text] [Related]
2. Effect of retinoic acid and palm oil carotenoids on oestrone sulphatase and oestradiol-17beta hydroxysteroid dehydrogenase activities in MCF-7 and MDA-MB-231 breast cancer cell lines.
Ng JH; Nesaretnam K; Reimann K; Lai LC
Int J Cancer; 2000 Oct; 88(1):135-8. PubMed ID: 10962451
[TBL] [Abstract][Full Text] [Related]
3. Modulation of oestrone sulphatase activity in breast cancer cell lines by growth factors.
Purohit A; Chapman O; Duncan L; Reed MJ
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):563-6. PubMed ID: 1562528
[TBL] [Abstract][Full Text] [Related]
4. Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells.
Nguyen BL; Ferme I; Chetrite G; Pasqualini JR
J Steroid Biochem Mol Biol; 1993 Jul; 46(1):17-23. PubMed ID: 8338787
[TBL] [Abstract][Full Text] [Related]
5. Control and expression of oestrone sulphatase activities in human breast cancer.
Pasqualini JR; Chetrite G; Nestour EL
J Endocrinol; 1996 Sep; 150 Suppl():S99-105. PubMed ID: 8943793
[TBL] [Abstract][Full Text] [Related]
6. Effect of transforming growth factor-beta1 on oestrogen metabolism in MCF-7 and MDA-MB-231 breast cancer cell lines.
Ee YS; Lai LC; Reimann K; Lim PK
Oncol Rep; 1999; 6(4):843-6. PubMed ID: 10373668
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of oestrone sulphatase activity in the MDA-MB-231 breast cancer cell line by breast cyst fluid from Malaysian women.
Elsadig RE; Reimann K; Yip CH; Lai LC
Anticancer Res; 2001; 21(4A):2693-6. PubMed ID: 11724341
[TBL] [Abstract][Full Text] [Related]
8. Effect of promegestone, tamoxifen, 4-hydroxytamoxifen and ICI 164,384 on the oestrone sulphatase activity of human breast cancer cells.
Chetrite G; Varin C; Delalonde L; Pasqualini JR
Anticancer Res; 1993; 13(4):931-4. PubMed ID: 8352561
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of steroid sulfatase activity by danazol.
Carlström K; Döberl A; Pousette A; Rannevik G; Wilking N
Acta Obstet Gynecol Scand Suppl; 1984; 123():107-11. PubMed ID: 6238495
[TBL] [Abstract][Full Text] [Related]
10. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells.
MacIndoe JH
Endocrinology; 1988 Sep; 123(3):1281-7. PubMed ID: 2969800
[TBL] [Abstract][Full Text] [Related]
11. Effect of transforming growth factor-beta1, insulin-like growth factor-I and insulin-like growth factor-II on cell growth and oestrogen metabolism in human breast cancer cell lines.
Wong SF; Reimann K; Lai LC
Pathology; 2001 Nov; 33(4):454-9. PubMed ID: 11827412
[TBL] [Abstract][Full Text] [Related]
12. The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumours.
Reed MJ; Purohit A; Duncan LJ; Singh A; Roberts CJ; Williams GJ; Potter BV
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):413-20. PubMed ID: 7626490
[TBL] [Abstract][Full Text] [Related]
13. Modulation of oestrone sulphate formation and hydrolysis in breast cancer cells by breast cyst fluid from British and Hungarian women.
Purohit A; Budai B; Wang DY; Willemsen EL; de Winkel A; Parish D; Ghilchik MW; Szamel I; Reed MJ
Br J Cancer; 2000 Jan; 82(2):492-6. PubMed ID: 10646910
[TBL] [Abstract][Full Text] [Related]
14. Effects of insulin-like growth factors I and II on oestrone sulphatase activity in human breast cancer cell lines.
Hwa IA; Reimann K; Lim PK; Lai LC
Int J Mol Med; 1999 Aug; 4(2):175-8. PubMed ID: 10402485
[TBL] [Abstract][Full Text] [Related]
15. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
Boylan M; van den Berg HW; Lynch M
Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of steroid sulphatase activity by steroidal methylthiophosphonates: potential therapeutic agents in breast cancer.
Purohit A; Howarth NM; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):523-7. PubMed ID: 8180114
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and biologic response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines. Effect of antiestrogens.
Pasqualini JR; Gelly C; Nguyen BL
Ann N Y Acad Sci; 1990; 595():106-16. PubMed ID: 2375600
[TBL] [Abstract][Full Text] [Related]
18. Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.
Journe F; Chaboteaux C; Dumon JC; Leclercq G; Laurent G; Body JJ
Br J Cancer; 2004 Nov; 91(9):1703-10. PubMed ID: 15477866
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
Selcer KW; Jagannathan S; Rhodes ME; Li PK
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
[TBL] [Abstract][Full Text] [Related]
20. Effect of the progestagen Promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells.
Pasqualini JR; Maloche C; Maroni M; Chetrite G
Anticancer Res; 1994; 14(4A):1589-93. PubMed ID: 7979190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
